Nexplanon recommended after second submission

22 October 2020 - The first submission was withdrawn. ...

Read more →

CADTH in favour of new indication for Soliris

22 October 2020 - CADTH has finalised its assessment of eculizumab for adult patients with refractory generalised myasthenia gravis. ...

Read more →

Patients, health organisations band together to bring breakthrough treatments to Canada sooner

21 October 2020 - Thirteen health charities and patient groups are calling on the Canadian government to improve access to ...

Read more →

Canadian baby with spinal muscular atrophy to get ‘world’s most expensive drug’

20 October 2020 - A little over a year ago, the idea of raising US$2.125 million to receive the “world’s ...

Read more →

Health charities and patient groups join together to protect access to breakthrough medical treatments in Canada

19 October 2020 - Patients shut out of process leading to the release of revised guidelines by the Patented Medicine Prices ...

Read more →

Health Canada has approved Taltz (ixekizumab) for the treatment of non-radiographic axial spondyloarthritis

19 October 2020 - Taltz is now approved to treat patients across the axSpA spectrum, including ankylosing spondylitis and non-radiographic axSpA. ...

Read more →

UCP approves policy to create private health care system in Alberta

18 October 2020 - Alberta’s United Conservative Party has voted to approve a policy that supports creating a “privately funded ...

Read more →

Health Canada approves Keytruda (pembrolizumab) as first-line treatment for patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma

15 October 2020 - Approval Based on Significant Overall Survival Findings from Phase 3 KEYNOTE-048 Trial. ...

Read more →

Health Canada approves first-ever gene replacement therapy, Luxturna

15 October 2020 - Luxturna (voretigene neparvovec), is the first approved therapy for previously untreatable inherited retinal disease. ...

Read more →

Moderna announces initiation of rolling submission to Health Canada for mRNA vaccine against COVID-19 (mRNA-1273)

13 October 2020 - Confirmation underscores Moderna’s commitment to make its vaccine available in Canada. ...

Read more →

Radiopharmaceutical cancer treatment Lutathera now available to Ontario patients with midgut neuroendocrine tumours

8 October 2020 - Lutathera is the first and only therapeutic radiopharmaceutical approved by Health Canada for the treatment of GEP-NETs. ...

Read more →

Rapid qualitative evidence syntheses in health technology assessment: experiences, challenges, and lessons

9 October 2020 - Health care decision makers are increasingly demanding that health technology assessment is patient focused, and considers data ...

Read more →

Health Canada approves Inqovi (decitabine and cedazuridine) oral therapy for two types of blood cancers, MDS and CMML

8 October 2020 - Oral drug can be taken at home, which may enable some patients to avoid some hospital visits. ...

Read more →

Pfizer Canada and BioNTech initiate rolling submission to Health Canada for SARS-CoV-2 vaccine candidate BNT162b2

9 October 2020 - Pfizer Canada and BioNTech will continue regular and open dialogue with Health Canada providing results from their ...

Read more →

Health Canada approves Zeposia, an oral treatment for relapsing remitting multiple sclerosis

7 October 2020 - Bristol Myers Squibb's medication provides a new oral treatment option for Canadians living with the neurological disease. ...

Read more →